Sell Off For Ishares Lehman 20 Yr (AMEX: TLT) Says Market Timer Frank Kollar
May 24, 2007
(FinancialWire) (By Frank Kollar)
Exchange-traded fund Ishares Lehman 20 Yr (AMEX: TLT) closed below a critical support level on Wednesday. The prior correction lows, reached back on January 29 th, were expected by many traders to stop the sell off in bonds, but that was not the case. What happens next?
The close below support indicates further declines in coming days. We expect TLT to reach $86.06 in short order. Should TLT make a decisive close below $86.06, it will open the door to even steeper declines, as low as $84.50, before the next support level is reached.
The Fibtimer.com (http://www.fibtimer.com) ETF Timing Strategy currently has a position in TLT.
Kollar’s research has shown that the financial markets are in tradable trends approximately 80 percent of the time. FibTimer strategies define trends and trade them in both advancing and declining markets. Caring nothing about what newscasters say or what the latest economic indicator predicts, trends are where the profits are, and that is where FibTimer is.
Kollar is editor and chief analyst at FibTimer.com (http://www.fibtimer.com) which offers market timing strategies for S&P and Nasdaq index fund traders, as well as bond, gold, small cap, sector, ETF and stock trading strategies.
Go to previous Trading Notes.
Note: These "Trading Notes" are short term in nature. They may or may not reflect the same position as current subscriber reports which typically have longer time frames.
© Copyright 1996-2007, Kollar Market Analytics, Inc., All Rights Reserved.
FibTimer reports may not be redistributed without permission. These Trading Notes however may be distributed without permission.
Disclaimer: The financial markets are risky. Investing is risky. Past performance
does not guarantee future performance. The foregoing has been prepared solely
for informational purposes and is not a solicitation, or an offer to buy or sell
any security. Opinions are based on historical research and data believed reliable,
but there is no guarantee that future results will be profitable. |